Becton, Dickinson (NYSE: BDX) is about to increase production of its SARS-CoV-2 diagnostic solution thanks to the largesse of two arms of the federal government. The healthcare equipment specialist announced Thursday that the Department of Defense (DOD), supported by the Department of Health and Human Services (HHS), is providing it with a $24 million investment for the purpose. The money will be devoted to the production of Becton, Dickinson’s Veritor System for Rapid Detection of SARS-CoV-2, a test that the company says can produce results within 15 minutes of being administered.
- DENSO Announces First Quarter Financial Results
- Dell hit with new layoffs, says cuts unrelated to COVID-19